Atsena Therapeutics, a clinical-stage gene therapy company focused on using the life-changing power of genetic medicine to reverse or prevent blindness, today announced that dosing is complete in ...
Retinoschisis affects the retina, causing problems with the central or peripheral vision. A person’s vision tends to worsen over time. In many cases, this is a natural result of aging, but it may ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. ATSN-201 received orphan drug designation from the FDA ...
Retinoschisis refers to the separation of the layers of the retina. The retina is the tissue inside the back of the eye that changes what you see into electrical signals that travel to the brain. When ...
Please provide your email address to receive an email when new articles are posted on . Atsena Therapeutics has dosed the first patient in its open-label, phase 1/2 LIGHTHOUSE study to evaluate the ...
Hosted on MSN
All You Need to Know About Retinoschisis
TYPES OF RETINOSCHISIS: JUVENILE X-LINKED AND DEGENERATIVE (SENILE) RETINOSCHISIS Retinoschisis refers to the splitting of the retinal layers, and it is mainly classified into Juvenile X-linked ...
Purpose To evaluate various published views regarding the management of complications of senile retinoschisis. Methods To analyze and compare various reports of studies of natural history and ...
Outcome of Regenerative Medicine Advanced Therapy (RMAT) meeting provides clear regulatory pathway to approval in a continuous Phase 1 / 2 / 3 study, avoiding the requirement for an additional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback